A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

BACKGROUND: VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. OBJECTIVE: To evaluate 12-month effectiveness and safety of VYC-17.5L for the treatment of moderate/severe nasolabial folds (NLFs). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattler, Gerhard, Philipp-Dormston, Wolfgang G., Van Den Elzen, Helga, Van Der Walt, Cornelius, Nathan, Myooran, Kolodziejczyk, Julia, Kerson, Graeme, Dhillon, Benjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414733/
https://www.ncbi.nlm.nih.gov/pubmed/28165349
http://dx.doi.org/10.1097/DSS.0000000000000939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414733/
https://www.ncbi.nlm.nih.gov/pubmed/28165349
http://dx.doi.org/10.1097/DSS.0000000000000939

Ejemplares similares